News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
234 Results
Type
Article (15)
Company Profile (1)
Press Release (218)
Section
Business (83)
Career Advice (1)
Deals (9)
Drug Development (34)
FDA (4)
Job Trends (32)
News (119)
Policy (3)
Tag
Alliances (8)
Approvals (4)
Best Places to Work (35)
Cancer (2)
Career advice (1)
Cell therapy (1)
Clinical research (38)
C-suite (1)
Data (8)
Earnings (48)
Events (52)
Executive appointments (3)
FDA (4)
Funding (1)
Government (1)
Healthcare (34)
Infectious disease (3)
Influenza (2)
IPO (9)
Job search strategy (1)
Lung cancer (1)
Manufacturing (1)
Mergers & acquisitions (1)
NextGen: Class of 2026 (1)
Now hiring (2)
Patient recruitment (3)
People (41)
Pharmaceutical (1)
Phase 1 (21)
Phase 2 (25)
Phase 3 (5)
Pipeline (11)
Preclinical (2)
Rare diseases (1)
Regulatory (2)
Series B (1)
Sickle cell disease (1)
Vaccines (12)
Date
Last 30 days (1)
Last 365 days (20)
2026 (13)
2025 (21)
2024 (39)
2023 (54)
2022 (51)
2021 (40)
2020 (16)
Location
Asia (6)
Australia (1)
California (45)
Europe (6)
Massachusetts (1)
Northern California (38)
Southern California (3)
United States (47)
Washington State (1)
234 Results for "vaxcyte".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update
May 7, 2026
·
16 min read
Press Releases
Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference
April 8, 2026
·
2 min read
Press Releases
Vaxcyte to Present at the Guggenheim Emerging Outlook: Biotech Summit
February 6, 2026
·
2 min read
Press Releases
Vaxcyte Announces Pricing of $550 Million Public Offering
January 30, 2026
·
4 min read
Press Releases
Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate
March 19, 2026
·
12 min read
Press Releases
Vaxcyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 25, 2026
·
18 min read
Press Releases
Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
March 23, 2026
·
14 min read
Press Releases
Vaxcyte to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on February 24, 2026
February 11, 2026
·
2 min read
Press Releases
Vaxcyte Announces Closing of $632.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 3, 2026
·
3 min read
Press Releases
Vaxcyte Doses First Participants in OPUS-3 Phase 3 Trial Evaluating VAX-31 in Adults Previously Vaccinated with Lower-Valency Pneumococcal Vaccines
February 12, 2026
·
11 min read
1 of 24
Next
